Identification of a Novel EML4-ALK Fusion Transcript in Lung Adenocarcinoma

被引：0
|
作者：
To, K. [1 ]
Tong, J. H. M. [1 ]
Law, P. P. Y. [1 ]
Chau, S. L. [1 ]
Lung, R. W. M. [1 ]
Yeung, S. F. [1 ]
Kang, W. [1 ]
机构：
[1] Chinese Univ Hong Kong, Shatin, Hong Kong, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2012年 / 7卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S218 / S219
页数：2
相关论文
共 50 条
  • [21] Primary lung adenocarcinoma with breast metastasis harboring the EML4-ALK fusion: A case report
    Zhang, Wenwen
    Zhang, Yu
    Zhou, Lei
    Tan, Na
    Bai, Yuju
    Xing, Shiyun
    [J]. ONCOLOGY LETTERS, 2024, 27 (06)
  • [22] The Prevalence of the EML4-ALK Fusion Gene in Cytology Specimens from Patients with Lung Adenocarcinoma
    Heriyanto, Didik S.
    Trisnawati, Ika
    Kumara, Evan G.
    Laiman, Vincent
    Yuliani, Fara S.
    Sumpono, Auliya S. B.
    Cempaka, Rita
    Marcellus
    Budiono, Eko
    [J]. PULMONARY MEDICINE, 2020, 2020
  • [23] Concomitant novel ALK-SSH2, EML4-ALK and ARID2-ALK, EML4-ALK double-fusion variants and confer sensitivity to crizotinib in two lung adenocarcinoma patients, respectively
    Tao, Hong
    Liu, Zhe
    Mu, Jing
    Gai, Fei
    Huang, Zhan
    Shi, Liang
    [J]. DIAGNOSTIC PATHOLOGY, 2022, 17 (01)
  • [24] Coexistence of a Novel NBAS-ALK, EML4-ALK Double-Fusion in a Lung Adenocarcinoma Patient With LM and Response to Ensartinib
    Xu, X.
    Li, N.
    Fan, Y.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S445 - S445
  • [25] Concomitant novel ALK-SSH2, EML4-ALK and ARID2-ALK, EML4-ALK double-fusion variants and confer sensitivity to crizotinib in two lung adenocarcinoma patients, respectively
    Hong Tao
    Zhe Liu
    Jing Mu
    Fei Gai
    Zhan Huang
    Liang Shi
    [J]. Diagnostic Pathology, 17
  • [26] EML4-ALK fusion lung cancer:: A rare acquired event
    Perner, Sven
    Wagner, Patrick L.
    Demichelis, Francesca
    Mehra, Rohit
    LaFargue, Chris J.
    Moss, Benjamin J.
    Arbogast, Stefanie
    Soltermann, Alex
    Weder, Walter
    Giordano, Thomas J.
    Beer, David G.
    Rickman, David S.
    Chinnaiyan, Arul M.
    Moch, Holger
    Rubin, Mark A.
    [J]. NEOPLASIA, 2008, 10 (03): : 298 - 302
  • [27] A case of lung adenocarcinoma harboring exon 19 EGFR deletion and EML4-ALK fusion gene
    Chen, Xiaoxia
    Zhang, Jie
    Hu, Qiong
    Li, Xuefei
    Zhou, Caicun
    [J]. LUNG CANCER, 2013, 81 (02) : 308 - 310
  • [28] A CASE OF LUNG ADENOCARCINOMA RESISTANT TO CRIZOTINIB HARBORING KRAS MUTATION AND EML4-ALK FUSION GENE
    Anai, Satoshi
    Suzuki, Kunihiro
    Sueishi, Katsuo
    Harada, Taishi
    Toyokawa, Gouji
    Seto, Takashi
    Takenoyama, Mitsuhiro
    Takayama, Koichi
    Ichinose, Yukito
    Nakanishi, Yoichi
    [J]. ANNALS OF ONCOLOGY, 2014, 25
  • [29] Prevalence of EML4-ALK Fusion Gene in Adenocarcinoma Lung Patients by Using Immuno Histo Chemistry
    Talwar, V.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (09) : S167 - S167
  • [30] EML4-ALK fusion gene and efficacy of an ALK kinase inhibitor in lung cancer
    Koivunen, Jussi P.
    Mermel, Craig
    Zejnullahu, Kreshnik
    Murphy, Carly
    Lifshits, Eugene
    Holmes, Alison J.
    Choi, Hwan Geun
    Kim, Jhingook
    Chiang, Derek
    Thomas, Roman
    Lee, Jinseon
    Richards, William G.
    Sugarbaker, David J.
    Ducko, Christopher
    Lindeman, Neal
    Marcoux, J. Paul
    Engelman, Jeffrey A.
    Gray, Nathanael S.
    Lee, Charles
    Meyerson, Matthew
    Janne, Pasi A.
    [J]. CLINICAL CANCER RESEARCH, 2008, 14 (13) : 4275 - 4283
12345